$24.3M
Qualified
maximum offering price, as qualified
—
Reported Sold
no 1-K or 1-Z states a sold amount
5
Filings
across 1 offering
Equity Classes
| Type | Class | Outstanding | CUSIP | Publicly Traded |
|---|---|---|---|---|
| common | Common Stock | 14,499,502 | 23666P200 | Nasdaq Capital Market |
| preferred | Series A Convertible Preferred | 65,640 | — | — |
Service Providers
| Role | Provider |
|---|---|
| auditor | Haskell & White LLP |
| legal | Sheppard Mullin Richter & Hampton LLP; Bevilacqua PLLC |
| sales commission | Digital Offering, LLC |
Offerings
| File Number | Filings | First Filed | Last Filed | Qualified | Price/Security | Securities Offered | Outstanding | Aggregate Offering | Estimated Net | Supplements | Last Supplement | CRD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 024-12688 | 3 | 2025-11-25 | 2026-03-30 | 2026-04-01 | $5.00 | 4,854,000 | 65,640 | $24.3M | $22.2M | 5 | 2026-08-19 | 166401 |
The statements and reported figures behind Dare Bioscience, Inc.
Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.
- Every caption as the filer wrote it, across every annual report — not just the latest 1-K
- Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
- A sparkline on each annual-statement line, so the shape is visible before the figures
- A revenue series dated to the filings that reported it
- A filing history that says what each document contributed, not only that it exists
- Follow it, and see it change on your watchlist
External link: SEC Filings